crystal-kwok-mhUsz2ezlXQ-unsplash.jpg
Transparent Image 1.png

ELEVATING THE SCIENCE OF CONCENTRATES

CONSULTING SERVICES TAILORED TO YOUR INDIVIDUAL OPERATION

RESEARCH &
DEVELOPMENT

Lab bench testing

for rigorous trials of theory

and novel process methods

PRODUCT
FORMULATION

Creation of new recipes

to expand upon client's

existing merchandise catalog

PROCESS
OPTIMIZATION

Exploring every avenue

to ensure that the facility

is running at ideal efficiency

 

LABORATORY
SCALE

Selecting the analytical and small scale equipment to support your research and development goals

PILOT
SCALE

Intermediate sizing and process design testing to ensure a smooth transition from bench to plant

PRODUCTION
SCALE

Full scale production and establishment of work flow procedures to create a sustainable and long lasting operation.

CLIENT TESTIMONIALS

Jason Showard and Greg Arias of Concentrated Science have made significant contributions to C-Click Life Science's conversion-as-a-service line of business. C-Click was founded to commercialize a patented process to convert CBD to THC without harsh solvents, in tunable concentrations of THC, and at 10-15% of the cost of current solution chemistry state-of-the-art. Concentrated Science developed the SOP for production of delta-8 and delta-9 THC with the inventor of the patent, Harvard chemistry professor Alex Nivorozkhin, and configured a low-cost, high-capacity production unit to scale output to 100L of distillate per day. The production unit that Concentrated Science designed can be equipped for 20% of the capital investment required for a unit with comparable output. Concentrated Science demonstrated expertise in all relevant areas of cannabinoid conversion, extraction, distillation, and formulation, extensive knowledge of available equipment, processing inputs (catalysts, solvents, neutralizing agents, clarifiers, etc.), and an uncommon understanding of the tradeoffs between throughput, cost, and quality. C-Click will continue to work with Concentrated Science as strategic partner as we introduce our CaaS offering in medical and adult use states in the US, as well as suitable foreign jurisdictions.

 

Charlie Synn

CEO

C-Click Life Sciences, Inc.

 

cclickfinal.png

CONTACT

Thanks for submitting!